Nutra Pharma Corporation
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases.
The company, through its subsidiaries, carries out basic drug discovery research and clinical development, and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process.
Currently, Nutra Pharma offers several drug products for sale for the treatment of pain: Cobroxin, the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain, Nyloxin and Nyloxin Extra Strength, the only non-narcotic and non-addictive treatment for severe (Stage 3) pain.
Nutra Pharma Corporation currently trades it shares on the OTCBB under the symbol "NPHC" .
»
Newsroom
»
Stock Quote
»
Website